Stay updated on Aeterna Zentaris Press Releases
Sign up to get notified when there's something new on the Aeterna Zentaris Press Releases page.

Latest updates to the Aeterna Zentaris Press Releases page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedCOSCIENS Biopharma Inc. has appointed Anna Biehn as the new CEO and reported its financial results for 2024, while previous updates on merger integration and trial results have been removed.SummaryDifference100%
- Check30 days agoChange DetectedThe webpage has been updated to include a new announcement from COSCIENS Biopharma Inc. regarding a management cease trade order, while the previous financial results report has been removed.SummaryDifference12%
- Check44 days agoChange DetectedThe page now includes a new announcement regarding a possible delay in filing year-end reporting documents for COSCIENS Biopharma Inc., while previous announcements related to Aeterna Zentaris Inc. have been removed.SummaryDifference27%
- Check52 days agoChange DetectedThe webpage now includes an announcement from COSCIENS Biopharma Inc. regarding successful Phase 1 results for a new clinical trial, while the previous announcement about Aeterna Zentaris has been removed.SummaryDifference24%
- Check131 days agoChange DetectedCOSCIENS Biopharma Inc. has provided a corporate update and highlighted its pipeline prioritization as of December 23, 2024, while the merger transaction between Aeterna Zentaris and Ceapro has been completed as of June 3, 2024.SummaryDifference12%
- Check167 days agoChange DetectedThe website has undergone significant changes with new additions, while the top and bottom sections have been removed.SummaryDifference3%
Stay in the know with updates to Aeterna Zentaris Press Releases
Enter your email address, and we'll notify you when there's something new on the Aeterna Zentaris Press Releases page.